Latest News
GlaxoSmithKline pulls application for new drug use
Charlotte Observer (N.C.), The | 7 hours 33 minutes ago
TRENTON, N.J. British drugmaker GlaxoSmithKline PLC said Monday it is temporarily withdrawing its application for U.S. ... (more)
Pharmasset: hepatitis C drug trial will continue
Fort Worth Star-Telegram (Texas) | 7 hours 34 minutes ago
The Associated Press NEW YORK ? Pharmasset Inc. said Monday that it will continue enrolling patients in a clinical trial of RG7128, a drug that is designed to treat the liver disease hepatitis C.... (more)
Light Reading - VOIP - AT&T Helps Cerner - Telecom News Wire
Light Reading | 7 hours 34 minutes ago
DALLAS -- Connecting associates around the world and collaborating with clients is now a quicker, more interactive process for global healthcare solutions provider Cerner (Nasdaq: CERN). Cerner began using the AT&T* Telepresence Solution, an immersive video technology that connects remote participants, earlier this year to help respond to client service requests in a timely manner and to conduct virtual business meetings with its associates, clients and business partners around the world.... (more)
Earnings Preview: Medtronic
Philadelphia Inquirer, The | 7 hours 38 minutes ago
WASHINGTON - Medtronic, the world's largest medical device maker, reports earnings for the second fiscal quarter of 2010 on Tuesday. The following is a summary of key developments and analyst opinion for the last period.... (more)
Britain's GlaxoSmithKline pulls application to sell enlarged prostate drug for blocking cancer
Sun (Baltimore), The | 7 hours 41 minutes ago
British drugmaker GlaxoSmithKline PLC said Monday it is temporarily withdrawing its application for U.S. approval of a drug to prevent prostate cancer.... (more)
Spray can prevent premature ejaculation: study
Yahoo! | 7 hours 42 minutes ago
WASHINGTON (Reuters) ? A spray that numbs the penis can help prevent premature ejaculation, doctors reported on Thursday, and drug maker Sciele Pharma Inc, a division of Japan's Shionogi, plans to file for U.S. approval next year.... (more)
Pharmasset says Roche will continue enrolling subjects in RG7128 trial after committee review
Hartford Courant (Conn.), The | 8 hours 5 minutes ago
Pharmasset Inc. said Monday that it will continue enrolling patients in a clinical trial of RG7128, a drug that is designed to treat the liver disease hepatitis C.... (more)
Rigel shares rise on RBC analyst upgrade
Seattle Times, The | 8 hours 22 minutes ago
Rigel Pharmaceuticals Inc. rose after an RBC Capital Markets analyst recommended buying shares of the drug developer based on his expectations the company will announce news of a partnership for a key drug candidate.... (more)
406 Stories |
RSS Feed
Sign up for AANP SmartBrief
Latest Blog Postsview more
Tales of the Grim Reaper from Montreal
Health business blog
Are Your Kids Active Enough?
Diet-Blog
Public Anxiety Meets The Democratic Effort to Get Health Care Done at All Costs
Health Care Blog, The
Grasping the Third Rail
Stayin' Alive
Companies in the news
- Aetna Incorporated
- BioCryst Pharmaceuticals Inc.
- Covidien Plc
- Dendreon Corp
- GlaxoSmithKline plc
- Highmark
- Impax Laboratories, Inc.
- Intuitive Surgical Inc
- Methodist Healthcare
- Mitsubishi Tanabe Pharma Corp.
- Novartis
- Novavax
- Ranbaxy Laboratories Inc
- Roche
- Sciele Pharma Inc
